Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma
NCT01765231
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
190
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis B
Interventions
DRUG:
Entecavir prophylaxis
DRUG:
Observation arm
Sponsor
Peking University